Alkermes (ALKS) EBT Margin Growth (3y) (2013 - 2026)
Alkermes (ALKS) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,840.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -134.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,626.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,686.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,570.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5,487.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -225.00 |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | -1,182.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,182.00 |
| Dec 31, 2025 | -2,188.00 |
| Sep 30, 2025 | 213,081.00 |
| Jun 30, 2025 | 106,590.00 |
| Mar 31, 2025 | 2,447.00 |
| Dec 31, 2024 | 29.00 |
| Sep 30, 2024 | 3,817.00 |
| Jun 30, 2024 | 2,738.00 |
| Mar 31, 2024 | 2,081.00 |
| Dec 31, 2023 | 3,032.00 |
| Sep 30, 2023 | 2,351.00 |
| Jun 30, 2023 | 5,605.00 |
| Mar 31, 2023 | 878.00 |
| Dec 31, 2022 | 8,872.00 |
| Sep 30, 2022 | -208,415.00 |
| Jun 30, 2022 | -102,463.00 |
| Mar 31, 2022 | 2,878.00 |
| Dec 31, 2021 | 15,196.00 |
| Sep 30, 2021 | 458.00 |
| Jun 30, 2021 | 989.00 |